Hematology & Medical Oncology

Clinical Faculty

Zachariah McIver, DO
Assistant Professor of Clinical Medicine

Biography
Dr. Zach McIver received his medical degree from Ohio University College of Osteopathic Medicine in 2004. He completed a residency in Internal Medicine at the Cleveland Clinic in 2007, and in 2011 completed a fellowship in Hematology at the National Heart, Lung, and Blood Institute in Bethesda, Maryland.

Dr. McIver joined the faculty of the Tulane University School of Medicine Section of Hematology and Medical Oncology in September 2011 as an Assistant Professor of Clinical Medicine. Dr. McIver’s research interests include improving outcomes for patients with a hematological malignancy receiving an allogeneic stem cell transplant, and the prevention of graft-versus-host disease.

He is a member of the American Society of Hematology, the American Society of Bone Marrow Transplant, and the American Osteopathic Association. He is board certified in Internal Medicine and Hematology.

Selected Publications

McIver, Z, Yin, F, Hughes, T, Battiwalla, M, Ito, S, Koklanaris, E, Haggerty, J, Hensel, N, Barrett, AJ, Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival. Bone Marrow Transplant 2013.

McIver, Z, Melenhorst, JJ, Wu, C, Grim, A, Ito, S, Cho, I, Hensel, N, Battiwalla, M, Barrett, AJ, Donor Lymphocyte Count and Thymic Activity Predict Lymphocyte Recovery and Outcomes after Matched-Sibling Hematopoietic Stem Cell Transplant. Haematologica. 2012 Oct 12.

Melenhorst, JJ, Tian, X, Xu, D, Sandler N, Scheinberg P, Biancotto, A, McIver, Z, Scheinberg, P, McCoy, JP, Jr., Hensel NF, Douek, DC, Barrett, AJ, Cytopenia and leucocyte recovery shapes cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation. Hematologica. 2012 Jun; 97(6):867-73.

Taylor J, Darbari D, Maric I, McIver Z, Arthur D; Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia. Ann Intern Med. 2011 Nov 15; 155(10):722-4.

McIver Z, Mielke S, Shenoy A, Fellowes V, Khuu H, Stroncek D, Leitman S, Childs R, Battiwalla M, Haggerty J, Savani BN, Rezvani K, Barrett AJ. Selectively T cell depleted allografts from HLA-matched sibling donors followed by low-dose post-transplant immunosuppression to reduce acute GVHD and disease relapse in patients with hematological malignancies. Biol Blood Marrow Transplant. 2011 May 30.

McIver Z, Melenhorst JJ, Grim A, Naguib N, Weber G, Fellowes V, Khuu H, Stroncek D, Leitman S, Battiwalla M, Barrett AJ. Immune Reconstitution Recipients of Photodepleted Stem Cell Transplants: T cell subset frequencies predict outcome. Biol Blood Marrow Transplant. 2011 May 31.

McIver Z, Stephens N, Grim A, Barrett AJ. Rituximab Administration within 6 months of T cell-depleted Allogeneic SCT is Associated with Prolonged Life-threatening Cytopenias. Bio Blood and Marrow Transplantation 2010 Nov;16(11):1549-56.

Thakkar SG, Fu AZ, Sweetenham JW, McIver Z, Mohan SR, Ramsingh G, Advani AS, Sobecks R, Rybicki L, Kalaycio M, Sekeres MA. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer 2008 May; 112(10):2233-40

McIver Z, Serio B, Dunbar A, O'Keefe CL, Powers J, Wlodarski M, Jin T, Sobecks R, Bolwell B, Maciejewski JP.Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2008 April; 141(2):170-8 (Impact factor 4.6)

O'Keefe CL, Gondek L, Davis R, Kuczkowski E, Sobecks RM, Rodriguez A, Narvaez Y, McIver Z, Tuthill R, Laughlin M, Bolwell B, Maciejewski JP.Molecular analysis of alloreactive CTL post-hemopoietic stem cell transplantation. J Immunol 2007 Aug; 179(3): 2013-22 (Impact factor 5.6)